Finite State vs MedCrypt (2026)
Both help medical device manufacturers meet FDA cybersecurity obligations, and both grade A on regulatory status and model transparency, so the question is where each starts. Finite State starts from the shipped artifact: it unpacks the binary itself across a reported 130 plus formats without source code access, deriving the true component inventory rather than trusting a supplied SBOM, which is decisive for the third party and off the shelf components manufacturers cannot inspect. MedCrypt starts from the submission: it maps precisely to the enforceable obligations under Section 524B and names its exploitability sources openly, and it is candid that its core is a rules engine over public feeds rather than a model. The honest divide is analytical depth against regulatory framing. If your failure mode is not knowing what is actually inside your firmware, start with Finite State, and ask it to validate its not affected reachability calls. If your failure mode is assembling a defensible FDA submission from transparent inputs, start with MedCrypt.
- It does not trust the SBOM it is handed: the platform unpacks the shipped artifact itself across a reported 130 plus binary formats and 30 plus architectures, revealing libraries and components inside encrypted or proprietary firmware without source code access, which is exactly where unknown risk accumulates.
- The most technically specific disclosure in the category, graded A on model transparency: binary composition analysis extracting control flow graphs and symbols, static analysis of decompiled code, and reachability analysis over call graphs, so a security engineer can judge whether it would work on their firmware from the description alone.
- Wider lifecycle and market coverage, graded A on setting: design through postmarket in one system of record, with regulatory mapping extending beyond FDA Section 524B to the EU Cyber Resilience Act.
- The clearest regulatory literacy in the lane, graded A: the product maps directly to the enforceable obligations under Section 524B, from SBOM minimum elements to per vulnerability risk assessments and postmarket monitoring, and the company publishes analysis of actual FDA premarket deficiency patterns.
- Auditable inputs rather than proprietary intelligence, graded A on model transparency: exploitability is built explicitly on EPSS, CISA KEV, ExploitDB, Metasploit, NVD, and CWE Top 25, all sources a buyer can evaluate independently, which almost nothing else in this lane permits.
- Honest about its own mechanism: MedCrypt's core is a rules engine over curated public feeds rather than a model, graded C on AI centrality, so what you buy is regulatory framing and transparency, not model quality.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Finite State and MedCrypt are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Finite State | MedCrypt |
|---|---|---|
| Primary category | Healthcare Cybersecurity | Healthcare Cybersecurity |
| Headquarters | Columbus, Ohio, United States | San Diego, California, United States |
| Website | finitestate.io | medcrypt.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Finite State its top capability grade on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Set against MedCrypt, Finite State grades higher on several axes, including AI Centrality, EHR and Interoperability Depth and Deployment Model and Data Residency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards MedCrypt its top capability grade on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Set against Finite State, MedCrypt does not grade higher on any scored axis, though the two are level on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Finite State or MedCrypt?
The AI Health Index grades Finite State higher than MedCrypt on every axis that separates them, several axes, including AI Centrality, EHR and Interoperability Depth and Deployment Model and Data Residency. MedCrypt does not grade higher on any scored axis.
Where do Finite State and MedCrypt differ most?
The widest separation the AI Health Index records between Finite State and MedCrypt is on AI Centrality, where Finite State grades B and MedCrypt grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Finite State and MedCrypt grade the same?
The AI Health Index grades Finite State and MedCrypt the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Healthcare Administrative Automation page.
This is the manufacturer side contrast pair, and both vendors grade A on FDA and regulatory status and on model transparency, so the split is method rather than compliance. Finite State grades B on AI centrality because its depth is program analysis rather than machine learning, still genuinely the product; MedCrypt grades C because its core is a rules engine over public feeds, which the index states plainly.
Finite State grades C on governance for a specific reason worth weighing: reachability analysis is used to justify not remediating a vulnerability, so a false negative produces a documented regulatory justification for leaving an exploitable flaw in a shipped device, a higher consequence error than over alerting.
Both vendors' performance claims are self generated case studies, graded C on evidence, and neither publishes a security attestation despite holding a complete map of customers' firmware. Neither processes PHI. Neither publishes pricing.